These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16267348)

  • 1. Combination therapy for chronic obstructive pulmonary disease: clinical aspects.
    Donohue JF
    Proc Am Thorac Soc; 2005; 2(4):272-81; discussion 290-1. PubMed ID: 16267348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM; Beier J
    Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?
    Reddy CB; Kanner RE
    Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.
    Hanania NA; Donohue JF
    Proc Am Thorac Soc; 2007 Oct; 4(7):526-34. PubMed ID: 17878465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?
    Baloira A
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):17-24. PubMed ID: 23551020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fixed Combination of a Long-Acting beta(2)-Agonist and an Inhaled Steroid. A Therapeutic Option for COPD?].
    Welte T
    Med Klin (Munich); 2003 Oct; 98(10):552-61. PubMed ID: 14586509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications for COPD: a review of effectiveness.
    Grimes GC; Manning JL; Patel P; Via RM
    Am Fam Physician; 2007 Oct; 76(8):1141-8. PubMed ID: 17990836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
    N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchodilators in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Buhl R; Rabe KF; Vogelmeier C; Welte T
    Med Klin (Munich); 2005 May; 100(5):246-54. PubMed ID: 15902378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future of chronic obstructive pulmonary disease management.
    D'Urzo A; Vogelmeier C
    Expert Rev Respir Med; 2012 Jun; 6(3):285-99. PubMed ID: 22788943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ; Liang X; Zhang JQ; Liu L; Fu WP; Zhao ZH; Dai LM
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.